TD-802 | Interleukin Related interleukin-related.com

Product Name :
TD-802

Search keywords :
TD-802

drugId :
null

Target Vo:
Not applicable

Target Vo Short Name :
Not applicable

Moa_Name:
Proteolysis

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Korea Research Institute Of Chemical Technology

Active Company_Name :
Korea Research Institute Of Chemical Technology

Active Indication_Name:
Prostatic Neoplasms, Castration-Resistant

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Satralizumab custom synthesis
Modotuximab Formula
BrdU Antibody (YA578): BrdU Antibody (YA578) is a non-conjugated and Rabbit origined monoclonal antibody, targeting to BrdU. It can be used for IHC-P,ICC/IF,FC assays with tag free, in the background of .

Author: Interleukin Related

Related Posts